annb0t
Top 20
MELBOURNE, Australia, Jan. 18, 2023 /PRNewswire/ -- 18 January 2023. Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today issues its Appendix 4C quarterly cash flow statement and accompanying Activities Report for the quarter ended 31 December 2022 (Q4 2022). All figures are in AUD$ unless otherwise stated1 and provided on an unaudited basis. (PRNewsfoto/Telix Pharmaceuticals Limited)
Financial Summary
Telix achieved positive cash flow from operating activities:...
>>> Read more: Telix Reports Fourth Quarter 2022 Financial Results
Financial Summary
Telix achieved positive cash flow from operating activities:...
>>> Read more: Telix Reports Fourth Quarter 2022 Financial Results
